This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66063638
rdf:type
wikibase:Item
schema:description
klinisch onderzoek клінічне випробування ensayu clínicu clinical trial
rdfs:label
A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless). A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless).
skos:prefLabel
A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless). A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless).
schema:name
A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless). A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless).
p:P1476
wds:Q66063638-B3E46C8E-FB84-4E0A-8D16-0F1AD756D6B5
wdt:P1476
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
p:P582
wds:Q66063638-C3927DAC-DF78-4826-A649-67739F91A459
wdt:P582
2020-09-28T00:00:00Z
p:P31
wds:Q66063638-6E8BA579-D370-4A75-A282-2CB3A7274C8E
wdt:P31
wd:Q30612
p:P580
wds:Q66063638-5E1E4B2E-D66C-44C0-BA86-B6311EA915B8
wdt:P580
2019-08-28T00:00:00Z
p:P6153
wds:Q66063638-BE53DD48-9B6A-485B-B4C3-6167413A08C9 wds:Q66063638-436FA3FF-83F6-4BE0-8EF4-2EA3CCFEE2D8 wds:Q66063638-06EB8652-877F-49AE-928C-DCB0819F83C2 wds:Q66063638-A7AC67F6-46E1-4EF4-9995-B851DCA73011 wds:Q66063638-AE87DF68-4FF0-44CA-A1C1-A2D4A70CBA47 wds:Q66063638-68E2C5B1-9635-4B1D-B83B-200EF4F09627 wds:Q66063638-7A70717E-0B65-4444-A760-8030F3142267 wds:Q66063638-C8AC2DAB-3848-4D29-A554-065F5B138D54
wdt:P6153
wd:Q30269674 wd:Q319239 wd:Q33526980 wd:Q49115 wd:Q168751 wd:Q27493190 wd:Q30270266 wd:Q213439
p:P4844
wds:Q66063638-87977882-C6A4-4432-AB49-B02CAD3E3152
wdt:P4844
wd:Q414225
p:P2899
wds:Q66063638-C17D2306-1995-4541-9D34-4C670EFE5B10
wdt:P2899
30
p:P1050
wds:Q66063638-43FC5D83-5F4A-4055-A953-9966A6DBEDB1
wdt:P1050
wd:Q11085
p:P1132
wds:Q66063638-620A4444-078D-41C9-9DFB-909844666D52
wdt:P1132
300
p:P4135
wds:Q66063638-2419811D-BD8E-4D5F-827F-1831AC9D3238
wdt:P4135
80
p:P8363
wds:Q66063638-BF5345CE-A587-4DC0-A4FC-59AE5A4C98EF
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66063638-6245F5CD-924F-4B75-9FFF-BF808180FC09
wdt:P3098
NCT04006210
p:P6099
wds:Q66063638-CCBFFD68-B83F-46FB-874F-9FD14187BF6E
wdt:P6099
wd:Q42824827